Citadel Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$335K Sell
98,629
-97,391
-50% -$330K ﹤0.01% 10221
2025
Q4
$559K Buy
196,020
+84,313
+75% +$217K ﹤0.01% 8761
2025
Q3
$295K Buy
111,707
+24,391
+28% +$53.9K ﹤0.01% 10406
2025
Q2
$196K Buy
87,316
+87,283
+264,494% +$193K ﹤0.01% 10696
2025
Q1
$71 Sell
33
-72,456
-100% -$167K ﹤0.01% 14340
2024
Q4
$175K Buy
72,489
+51,087
+239% +$121K ﹤0.01% 10653
2024
Q3
$52.2K Buy
+21,402
New +$52.2K ﹤0.01% 11859
2024
Q2
Hold
0
15142
2024
Q1
Sell
-31,347
Closed -$87.7K 15313
2023
Q4
$72.4K Buy
+31,347
New +$67K ﹤0.01% 11347
2023
Q3
Hold
0
14914
2023
Q2
Sell
-54,162
Closed -$174K 15037
2023
Q1
$118K Sell
54,162
-1,979
-4% -$6.29K ﹤0.01% 11023
2022
Q4
$675K Sell
56,141
-50,725
-47% -$394K ﹤0.01% 7619
2022
Q3
$692K Sell
106,866
-541,967
-84% -$4.39M ﹤0.01% 7765
2022
Q2
$2.97M Buy
648,833
+463,354
+250% +$2.48M ﹤0.01% 4773
2022
Q1
$1.6M Sell
185,479
-348,746
-65% -$3.57M ﹤0.01% 6580
2021
Q4
$7.63M Buy
534,225
+515,329
+2,727% +$10.8M 0.01% 3542
2021
Q3
$416K Sell
18,896
-17,498
-48% -$298K ﹤0.01% 10325
2021
Q2
$487K Buy
36,394
+16,959
+87% +$194K ﹤0.01% 10116
2021
Q1
$198K Buy
+19,435
New +$160K ﹤0.01% 11716
2020
Q4
Sell
-32,537
Closed -$106K 11439
2020
Q3
$85K Buy
+32,537
New +$113K ﹤0.01% 9361
2020
Q2
Hold
0
10364
2020
Q1
Hold
0
10042
2019
Q4
Hold
0
9610
2015
Q4
Sell
-5,236
Closed -$29K 9068
2015
Q3
$29K Buy
5,236
+5,139
+5,298% +$32.3K ﹤0.01% 7941
2015
Q2
$1K Buy
+97
New +$664 ﹤0.01% 8645
2015
Q1
Sell
-6,921
Closed -$32K 8767
2014
Q4
$32K Buy
+6,921
New +$45.5K ﹤0.01% 7507
2014
Q3
Hold
0
8342

Other funds holding ORMP